Sponsor Pipeline

Guangxi Medical University Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
9
Active Trials
4
Recruiting
1
Phase 3
5
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-09 NCT05898256
Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma
overall status: Not Yet Recruiting → Unknown
Active Trials by Phase
Phase 3
1
Phase 2
1
Not specified
7
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07417397 Adjuvant TACE in HCC With High-risk Recurrence Factors Hepatocellular Carcinoma Recruiting
Phase 2
NCT05340270 PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal… Nasopharyngeal Carcinoma Active, Not Recruiting
Not specified
NCT06405321 Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma Hepatocellular Carcinoma Recruiting
NCT07614256 Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction Prostate Cancer (Diagnosis) Recruiting
NCT07561073 Comparison of Partial Stomach-Partitioning and Conventional Gastrojejunostomy for the… Gastric Cancer Recruiting
NCT07265193 The Workplace-Based Hypertension Management Program Hypertension Not Yet Recruiting
NCT07631806 Intelligent Screening and Precision Diagnosis of Prostate Cancer Based on Multimodal Data Prostate Cancer With PSA Gray Zone Active, Not Recruiting
NCT07658573 AI Multimodal Model for Predicting CRPC Progression Risk Prostate Cancer Active, Not Recruiting
NCT07658586 AI Multimodal Model for Liver Cancer Diagnosis and Prognosis Liver Cancer Active, Not Recruiting
Disease Areas
Get alerts when Guangxi Medical University's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free